콘텐츠로 건너뛰기
Merck
  • Heterocyclic bibenzimidazole derivatives as topoisomerase I inhibitors.

Heterocyclic bibenzimidazole derivatives as topoisomerase I inhibitors.

Bioorganic & medicinal chemistry letters (2000-04-27)
S Jin, J S Kim, S P Sim, A Liu, D S Pilch, L F Liu, E J LaVoie
초록

A series of 2'-heterocyclic derivatives of 5-phenyl-2,5'-1H-bibenzimidazoles were evaluated for topoisomerase I poisoning activity and cytotoxicity. Topo I poisoning activity was associated with 2'-derivatives that possessed a hydrogen atom capable of hydrogen bond formation, suggesting that the interatomic distances between such hydrogen atoms and the heteroatoms on the adjacent benzimidazole influence activity.

MATERIALS
제품 번호
브랜드
제품 설명

Sigma-Aldrich
Indole-5-carboxaldehyde, 98%